These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33852930)

  • 1. Asymptomatic COVID-19 cases among older patients despite BNT162b2 vaccination: A case series in a geriatric rehabilitation ward during an outbreak.
    Donadio C; Rainone A; Gouronnec A; Belmin J; Lafuente-Lafuente C
    J Infect; 2021 Jul; 83(1):119-145. PubMed ID: 33852930
    [No Abstract]   [Full Text] [Related]  

  • 2. Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.
    Salvagno GL; Henry BM; Pighi L; De Nitto S; Gianfilippi GL; Lippi G
    J Infect; 2021 Aug; 83(2):e4-e5. PubMed ID: 34214516
    [No Abstract]   [Full Text] [Related]  

  • 3. Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution.
    Baj A; Novazzi F; Genoni A; Ferrante FD; Taborelli S; Pini B; Partenope M; Valli M; Gasperina DD; Capuano R; Prestia M; Spezia PG; Azzi L; Focosi D; Maggi F
    Emerg Microbes Infect; 2021 Dec; 10(1):1254-1256. PubMed ID: 34110974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First Dose of BNT162b2 mRNA Vaccine in a Healthcare Worker Cohort Is Associated With Reduced Symptomatic and Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
    Lillie PJ; O'Brien P; Lawtie M; Jessop S; Easom NJW; Patmore R
    Clin Infect Dis; 2021 Nov; 73(10):1906-1908. PubMed ID: 33893480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
    Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won.
    Torreggiani M; Blanchi S; Fois A; Fessi H; Piccoli GB
    Kidney Int; 2021 Jun; 99(6):1494-1496. PubMed ID: 33887320
    [No Abstract]   [Full Text] [Related]  

  • 7. High anaphylaxis rates following vaccination with the Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers: a secondary analysis of initial post-approval safety data.
    Hashimoto T; Ozaki A; Bhandari D; Sawano T; Sah R; Tanimoto T
    J Travel Med; 2021 Oct; 28(7):. PubMed ID: 34128049
    [No Abstract]   [Full Text] [Related]  

  • 8. A Series of Patients With Myocarditis Following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2.
    Dickey JB; Albert E; Badr M; Laraja KM; Sena LM; Gerson DS; Saucedo JE; Qureshi W; Aurigemma GP
    JACC Cardiovasc Imaging; 2021 Sep; 14(9):1862-1863. PubMed ID: 34246585
    [No Abstract]   [Full Text] [Related]  

  • 9. Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine.
    Terpos E; Trougakos IP; Apostolakou F; Charitaki I; Sklirou AD; Mavrianou N; Papanagnou ED; Liacos CI; Gumeni S; Rentziou G; Korompoki E; Papassotiriou I; Dimopoulos MA
    Am J Hematol; 2021 Jul; 96(7):E257-E259. PubMed ID: 33837984
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of SARS-CoV-2 vaccination among health care workers in a geriatric care unit after a B.1.1.7-variant outbreak.
    Tanislav C; El Ansari T; Meyer M; Müller M; Grübener R; Stein T; Niemöller U; Baaske J; Kostev K; Rolfs A; Rosenbauer J
    Public Health; 2021 Sep; 198():e20-e22. PubMed ID: 34284878
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection.
    Gobbi F; Buonfrate D; Moro L; Rodari P; Piubelli C; Caldrer S; Riccetti S; Sinigaglia A; Barzon L
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33807957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
    Roest S; Hoek RAS; Manintveld OC
    N Engl J Med; 2021 May; 384(20):1968-1970. PubMed ID: 33882226
    [No Abstract]   [Full Text] [Related]  

  • 13. Skin manifestations of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers. 'COVID-arm': a clinical and histological characterization.
    Fernandez-Nieto D; Hammerle J; Fernandez-Escribano M; Moreno-Del Real CM; Garcia-Abellas P; Carretero-Barrio I; Solano-Solares E; de-la-Hoz-Caballer B; Jimenez-Cauhe J; Ortega-Quijano D; Fernandez-Guarino M
    J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):e425-e427. PubMed ID: 33783873
    [No Abstract]   [Full Text] [Related]  

  • 14. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply.
    Barda N; Dagan N; Balicer RD
    N Engl J Med; 2021 May; 384(20):1970. PubMed ID: 33882227
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization.
    Chodick G; Tene L; Patalon T; Gazit S; Ben Tov A; Cohen D; Muhsen K
    JAMA Netw Open; 2021 Jun; 4(6):e2115985. PubMed ID: 34097044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination.
    Fueyo-Rodriguez O; Valente-Acosta B; Jimenez-Soto R; Neme-Yunes Y; Inclán-Alarcón SI; Trejo-Gonzalez R; García-Salcido MÁ
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34059544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Not Available].
    Klimek L; Chaker AM; Cuevas M
    Laryngorhinootologie; 2021 Mar; 100(3):168-173. PubMed ID: 33482671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response to first and second dose of BNT162b2 in a cohort of characterized healthcare workers.
    Padoan A; Dall'Olmo L; Rocca FD; Barbaro F; Cosma C; Basso D; Cattelan A; Cianci V; Plebani M
    Clin Chim Acta; 2021 Aug; 519():60-63. PubMed ID: 33857476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2: a case report.
    Mücke VT; Knop V; Mücke MM; Ochsendorf F; Zeuzem S
    BMC Infect Dis; 2021 Sep; 21(1):958. PubMed ID: 34530771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse Reactions of the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers in Korea.
    Lee YW; Lim SY; Lee JH; Lim JS; Kim M; Kwon S; Joo J; Kwak SH; Kim EO; Jung J; Kwon HS; Kim TB; Kim SH; Bae S
    J Korean Med Sci; 2021 May; 36(21):e153. PubMed ID: 34060261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.